HOME MARKET NEWS CENTRE IPO ABOUT US Research Stock-Screener 17 May, 2024 15:09 IST Get Quote Snapshot Charts Financials Research News

my Last 5 Scrips Company BSE Price(Rs) % Chg Yes Bank 24.08 42.49 Tata Stl 136.20 30.33 Ong Corp 256.00 95.64 I T C Lt 438.65 28.62 Ntpc Ltd 319.00 89.15 Clear All Clear Last
Shares
NSE Live Nifty Live Prices Top Gainers/Losers Top 10 Turnover
BSE Live BSE30 Live Prices Top Gainers/Losers Top 10 Turnover
Market Pulse Leaders Laggards FII Activity
Research Research Reports

Alembic Pharmaceuticals Limited

Pharmaceuticals - Bulk Drugs and Formulations BSE:533573 NSE:APLLTD Bloomberg:ALPM@IN Reuters:ALEM.BO Market Lot: 1 Face Value: 2 ISIN Demat: INE901L01018

Quotes Charts Financials Research Recent News MF Holding BSE/NSE Notices

Corporate News 08-Mar-2022       Alembic Pharma JV gets USFDA's final approval for Nystatin and Triamcinolone Acetonide Ointment IRIS 02-Feb-2022       Alembic Pharmaceuticals gets USFDA nod for Fesoterodine Fumarate Extended-Release Tablets IRIS 10-Jan-2022       Alembic Pharmaceuticals gets USFDA nod for Dronedarone Tablets IRIS 08-Dec-2021       Alembic Pharmaceuticals gets USFDA nod for Selexipag Tablets IRIS 12-Oct-2021       Alembic Pharmaceuticals gets EIR from USFDA for Gujarat new injectable facility IRIS 06-Sep-2021       Alembic Pharmaceuticals joint venture gets USFDA final nod for Metronidazole Gel IRIS 05-Aug-2021       Alembic Pharma gets USFDA final nod for Clomipramine Hydrochloride Capsules  IRIS 08-Jul-2021       Alembic Pharmaceuticals gets USFDA nod for Desipramine Hydrochloride Tablets  IRIS 02-Jul-2021       Alembic Pharmaceuticals announces USFDA nod for Nitrofurantoin Capsules IRIS

 

© All rights reserved. IRIS Business Services Limited Disclaimer